UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies

Gynecologic oncology, 2014-05, Vol.133 (2), p.274-277

2014

Volltextzugriff (PDF)

Small cell cancers of the female genital tract: Molecular and clinical aspects

Gynecologic oncology, 2018-05, Vol.149 (2), p.420-427

2018

Volltextzugriff (PDF)

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center

Gynecologic oncology, 2016-03, Vol.140 (3), p.436-442

2016

Volltextzugriff (PDF)

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma

Gynecologic oncology, 2016-05, Vol.141 (2), p.260-263

2016

Volltextzugriff (PDF)

Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?

Gynecologic oncology, 2017-04, Vol.145 (1), p.15-20

2017

Volltextzugriff (PDF)

Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer

Gynecologic oncology, 2015-08, Vol.138 (2), p.246-251

2015

Volltextzugriff (PDF)

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas

Gynecologic oncology, 2010-10, Vol.119 (1), p.38-42

2010

Volltextzugriff (PDF)

Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach

Gynecologic oncology, 2017-07, Vol.146 (1), p.101-108

2017

Volltextzugriff (PDF)

A microRNA survival signature (MiSS) for advanced ovarian cancer

Gynecologic oncology, 2011-06, Vol.121 (3), p.444-450

2011

Volltextzugriff (PDF)

Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis

Gynecologic oncology, 2013-08, Vol.130 (2), p.369-376

2013

Volltextzugriff (PDF)

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach

Gynecologic oncology, 2004-09, Vol.94 (3), p.650-654

2004

Volltextzugriff (PDF)

Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma

Gynecologic oncology, 2014-10, Vol.135 (1), p.49-53

2014

Volltextzugriff (PDF)

Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: Technique and review of the literature

Gynecologic oncology, 2006-12, Vol.103 (3), p.807-813

2006

Volltextzugriff (PDF)

Gynecologic cancer genomics in the modern era

Gynecologic oncology, 2013-03, Vol.128 (3), p.407-408

2013

Volltextzugriff (PDF)

Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer

Gynecologic oncology, 2012-01, Vol.124 (1), p.59-62

2012

Volltextzugriff (PDF)

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Gynecologic oncology, 2018-08, Vol.150 (2), p.274-281

2018

Volltextzugriff (PDF)

A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery

Gynecologic oncology, 2009-07, Vol.114 (1), p.111-116

2009

Volltextzugriff (PDF)

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

Gynecologic oncology, 2009-07, Vol.114 (1), p.26-31

2009

Volltextzugriff (PDF)

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Gynecologic oncology, 2021-04, Vol.161 (1), p.113-121

2021

Volltextzugriff (PDF)

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)

Gynecologic oncology, 2012-01, Vol.124 (1), p.10-14

2012

Volltextzugriff (PDF)

A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

Gynecologic oncology, 2018-06, Vol.149 (3), p.585-591

2018

Volltextzugriff (PDF)

Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses

Gynecologic oncology, 2018-07, Vol.150 (1), p.127-135

2018

Volltextzugriff (PDF)

Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study

Gynecologic oncology, 2022-02, Vol.164 (2), p.245-253

2022

Volltextzugriff (PDF)

Genetic predisposition to bevacizumab-induced hypertension

Gynecologic oncology, 2017-12, Vol.147 (3), p.621-625

2017

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

KollektionMEDLINE

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(104)

Sprache

Englisch
(104)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(103)
Humans
(99)
Female
(85)
Obstetrics & Gynecology
(60)
Oncology
(58)
Middle Aged
(52)
Adult
(50)
Aged
(48)
Obstetrics And Gynecology
(41)
Hematology, Oncology And Palliative Medicine
(40)
Aged, 80 And Over
(31)
Ovarian Neoplasms - Pathology
(31)
Neoplasm Staging
(30)
Ovarian Cancer
(23)
Male
(20)
Ovarian Neoplasms - Surgery
(20)
Biological And Medical Sciences
(17)
Treatment Outcome
(17)
Medical Sciences
(16)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies

Small cell cancers of the female genital tract: Molecular and clinical aspects

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma

Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?

Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas

Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach

A microRNA survival signature (MiSS) for advanced ovarian cancer

Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach

Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma

Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: Technique and review of the literature

Gynecologic cancer genomics in the modern era

Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)

A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses

Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study

Genetic predisposition to bevacizumab-induced hypertension

Aktive Filter

Suchergebnisse filtern